This website uses cookies. By continuing you are agreeing to our privacy policy.

American Lung Association's 'State of Lung Cancer' 2019 Report Finds Rhode Island Has a High Incidence Rate of Lung Cancer

Second annual report from American Lung Association explores how states can act to save more lives, support patients and families facing lung cancer

(November 13, 2019) - Providence, RI

For more information please contact:

Jennifer Solomon
[email protected]
(516) 680-8927

Lung cancer is the #1 cancer killer of women and men in the United States. While it’s estimated that 940  Rhode Island residents will be diagnosed with this disease in 2019 alone, fortunately more Americans than ever are surviving the disease according to a new report from the American Lung Association. 

The annual “State of Lung Cancer” report examines the toll of lung cancer throughout the nation, and outlines steps every state can take to better protect its residents from lung cancer. This year’s “State of Lung Cancer” seeks to continue the positive trend of increased lung cancer survival, as the nationwide five-year lung cancer survival rate of 21.7%, up from 17.2% a decade ago, reflects a 26% improvement over the past 10 years. In Rhode Island the survival rate is 23.7% but the incidence rate for new cases is higher than average, with 71 new cases for every 100,000 people.  Rhode Island ranks 43rd out of 51 states and Washington D.C. for new cases.   

“While we celebrate that more Americans than ever are surviving lung cancer, the disease remains the leading cause of cancer deaths, and much more can and must be done in Rhode Island to prevent the disease and support families facing the disease,” said Jennifer Wall, Director of Advocacy for the American Lung Association in Rhode Island. “We encourage Rhode Island’s elected leaders to continue to promote screenings for high risk individuals, and promote testing of homes and schools for radon – the second leading cause of lung cancer.”  

Wall added, “Since the data for this report was collected, Rhode Island’s Medicaid fee-for-service program has started covering lung cancer screenings, giving more people access to potentially life saving scans.  Now, we have to make sure people are aware of both access and eligibility so they can benefit from early detection.”

Part of the reason that lung cancer is so deadly is because most lung cancer cases are diagnosed at a later stage, after the disease has spread. Lung cancer screening is the key to early detection, when the disease is most curable, but only 21.5% of lung cancer cases nationally are diagnosed at an early stage. While this simple screening test has been available since 2015, only 4.8% of those eligible in Rhode Island have been screened.  The newly implemented coverage will likely increase that number for future reports. 

Dr. Saurabh Agarwal, a cardiothoracic radiologist at Rhode Island Medical Imaging and Brown University, and Chair of the American Lung Association's Rhode Island LUNG FORCE Expo said, “This simple test - lung cancer screening - is a powerful tool to save lives, and yet we’re only seeing a fraction of those who qualify actually getting screened. We are working to bring more awareness of screenings to the general public, but also to continue to push the medical community to offer these screenings to high risk patients, the same way they encourage tests like colonoscopies and mammograms.” 

The "State of Lung Cancer" 2019 report finds that the burden of lung cancer varies on a state by state basis. By better understanding the impact of lung cancer across the nation, efforts and policies can be focused where the needs are greatest, and this year’s report finds Rhode Island can and must do more to protect residents from lung cancer. Below are the key findings for Rhode Island

  • Survival: Lung cancer has one of the lowest five-year survival rates because cases are often diagnosed at later stages when it is less likely to be curable. Rhode Island ranks #9 at 23.7%.
  • Early Diagnosis: Nationally, only 21.5 % of cases are diagnosed at an early stage when the five-year survival rate is much higher (57.7%). Unfortunately, about 48.5% of cases are not caught until a late stage when the survival rate is only 6%. Rhode Island ranks among highest at 23.4%.
  • Surgical Treatment: Lung cancer can often be treated with surgery if it is diagnosed at an early stage and has not spread widely. Nationally, 20.6 % of cases underwent surgery. Rhode Island ranks among the top, falling behind only Massachusetts at 27.6%.
  • Lack of Treatment: There are multiple reasons why patients may not receive treatment. Some of these reasons may be unavoidable, but no one should go untreated because of lack of provider or patient knowledge, stigma associated with lung cancer, fatalism after diagnosis, or cost of treatment. Nationally, about 15.4% of cases receive no treatment. Rhode Island ranks better than average with only 11.6 % of patients receiving no treatment.
  • Screening and Prevention: Screening for lung cancer with annual low-dose CT scans among those who qualify can reduce the lung cancer death rate by up to 20%. Nationally, only 4.2% of those who qualify were screened. Rhode Island came in close to average with 4.8% of high risk patients being screened.  

Learn more about "State of Lung Cancer" at Lung.org/solc. For media interested in speaking with a medical expert about the "State of Lung Cancer" 2019 report or lung cancer survivor about their experience, contact Jennifer Solomon at the American Lung Association at [email protected] or 516-680-8927.

Background on the Report 

The American Lung Association’s “State of Lung Cancer” 2019 is the second report we have released on key lung cancer statistics for each state. The 2019 report uses data from the North American Association of Central Cancer Registries (NAACCR), Centers for Disease Control and Prevention (CDC), and American College of Radiology (ACR), among other sources. Analysis of this data is conducted by the American Lung Association Epidemiology and Statistics team.

###

About the American Lung Association

The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease, through research, education and advocacy. The work of the American Lung Association is focused on four strategic imperatives: to defeat lung cancer; to improve the air we breathe; to reduce the burden of lung disease on individuals and their families; and to eliminate tobacco use and tobacco-related diseases. For more information about the American Lung Association, a holder of the coveted 4-star rating from Charity Navigator and a Gold-Level GuideStar Member, or to support the work it does, call 1-800-LUNGUSA (1-800-586-4872) or visit: Lung.org.

Red button with telephone
Ask An Expert

Questions about your lung health? Need help finding healthcare? Call 1-800-LUNGUSA.

Get help
Red button of two hand prints
We need your generous support

Make a difference by delivering research, education and advocacy to those impacted by lung disease.

Button of turquoise LUNG FORCE swirl
What is LUNG FORCE?

LUNG FORCE unites women and their loved ones across the country to stand together in the fight against lung cancer.

Get involved
Join the fight for healthy lungs and healthy air.
Donate Now.